Tag: Boston
Biogen CEO Plans to Acquire Biotechs: Expect Deals Ahead
Biogen CEO Eyes Biotech Acquisitions: Anticipate Major Deals in 2025SAN FRANCISCO — Chris Viehbacher, the CEO of Biogen, revealed his company's ambitious plans to...
Top Predictions from Four Digital Health Unicorns for 2025
Leaders of Digital Health Unicorns Reflect on 2024 and Predictions for 2025In the fast-paced world of digital health, 2024 was a year of significant...
Advancing RNA-Based Drugs in Rare Diseases: Sarepta and Arrowhead Pharmaceuticals Partnership
Sarepta Therapeutics has announced a significant partnership with Arrowhead Pharmaceuticals to develop RNA-based drugs for rare diseases. The deal includes a $500 million cash...
Biotech Analyst and CEO Discuss Election Results: Insights from Brian Skorney and Daphne Zohar
Biotech analyst Brian Skorney and biotech executive Daphne Zohar recently appeared on "The Readout LOUD" podcast to share their thoughts on how the outcomes...
BREAKING NEWS
Medicare Coverage of Wegovy Should Include, But Not Negotiate Price
Title: Biden Administration's Decision on Wegovy Medicare Coverage Sparks ControversyPresident Biden's recent announcement regarding the Medicare coverage of Wegovy, a GLP-1 obesity medication, has...
